Dr. Patricia Kapsner, MD
NPI: 1710993464
Total Payments
$22,142
2024 Payments
$198.74
Companies
25
Transactions
93
Medicare Patients
562
Medicare Billing
$36,378
Payment Breakdown by Category
Research$18,850 (85.1%)
Food & Beverage$3,283 (14.8%)
Education$8.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18,850 | 2 | 85.1% |
| Food and Beverage | $3,283 | 90 | 14.8% |
| Education | $8.35 | 1 | 0.0% |
Payments by Type
Research
$18,850
2 transactions
General
$3,292
91 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $18,850 | 2 | $0 (2017) |
| Lilly USA, LLC | $706.28 | 27 | $0 (2023) |
| Amgen Inc. | $517.12 | 7 | $0 (2023) |
| Insulet Corporation | $345.83 | 13 | $0 (2024) |
| Ultragenyx Pharmaceutical Inc. | $208.69 | 3 | $0 (2022) |
| UCB, Inc. | $184.43 | 2 | $0 (2018) |
| Corcept Therapeutics | $137.99 | 2 | $0 (2019) |
| Abbott Laboratories | $124.20 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $121.80 | 1 | $0 (2019) |
| Radius Health, Inc. | $121.80 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $198.74 | 3 | CeQur Corporation ($96.11) |
| 2023 | $729.09 | 17 | Insulet Corporation ($242.36) |
| 2022 | $290.53 | 4 | Ultragenyx Pharmaceutical Inc. ($98.91) |
| 2021 | $111.56 | 2 | Amgen Inc. ($93.58) |
| 2020 | $375.76 | 15 | Lilly USA, LLC ($153.98) |
| 2019 | $671.84 | 29 | Lilly USA, LLC ($188.17) |
| 2018 | $493.93 | 14 | Lilly USA, LLC ($172.04) |
| 2017 | $19,270 | 9 | NOVARTIS PHARMACEUTICALS CORPORATION ($18,850) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 02/22/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $86.79 | General |
| Category: Insulin Pump | ||||||
| 02/07/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $96.11 | General |
| Category: Diabetes | ||||||
| 11/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Diabetes | ||||||
| 09/29/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $87.32 | General |
| Category: Oncology | ||||||
| 09/28/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $66.59 | General |
| Category: Hyperthyroidism | ||||||
| 09/20/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $10.71 | General |
| Category: Insulin Pump | ||||||
| 09/05/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.86 | General |
| Category: Insulin Pump | ||||||
| 08/30/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $105.51 | General |
| Category: Endocrinology | ||||||
| 08/27/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.53 | General |
| Category: Insulin Pump | ||||||
| 07/23/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $9.21 | General |
| Category: Insulin Pump | ||||||
| 05/26/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $124.20 | General |
| Category: Diabetes Care | ||||||
| 05/18/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $9.70 | General |
| Category: Insulin Pump | ||||||
| 04/26/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $86.57 | General |
| Category: Bone Health | ||||||
| 04/19/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $8.32 | General |
| Category: Insulin Pump | ||||||
| 04/02/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $3.39 | General |
| Category: Insulin Pump | ||||||
| 03/13/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Insulin Pump | ||||||
| 03/13/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $6.28 | General |
| Category: Insulin Pump | ||||||
| 02/24/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $56.17 | General |
| Category: Insulin Pump | ||||||
| 02/16/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $106.12 | General |
| Category: Insulin Pump | ||||||
| 11/17/2022 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $95.81 | General |
| Category: Bone Health | ||||||
| 07/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $95.81 | General |
| Category: Diabetes | ||||||
| 03/16/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $80.19 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 02/22/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 11/04/2021 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $93.58 | General |
| Category: Bone Health | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $18,850 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 92 | $20,710 | $6,300 |
| 2022 | 7 | 171 | 222 | $21,426 | $7,436 |
| 2021 | 8 | 220 | 265 | $32,099 | $13,321 |
| 2020 | 3 | 90 | 138 | $31,854 | $9,321 |
Total Patients
562
Total Services
717
Medicare Billing
$36,378
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 45 | $8,628 | $3,003 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $7,010 | $1,696 | 24.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 11 | $3,692 | $930.62 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $1,380 | $670.19 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 50 | $9,518 | $3,133 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 35 | $8,830 | $2,566 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,537 | $712.65 | 46.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 17 | 25 | $561.00 | $400.10 | 71.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 16 | 24 | $276.00 | $216.03 | 78.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 17 | $290.00 | $154.58 | 53.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 46 | $198.00 | $137.58 | 69.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 11 | 12 | $216.00 | $115.83 | 53.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 99 | $20,556 | $8,390 | 40.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 23 | $3,475 | $1,389 | 40.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,731 | $1,374 | 50.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 15 | $3,690 | $1,189 | 32.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 19 | 22 | $510.00 | $343.20 | 67.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 17 | 22 | $410.00 | $215.72 | 52.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 18 | 20 | $272.00 | $166.22 | 61.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 14 | 15 | $305.00 | $140.10 | 45.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 29 | 38 | $150.00 | $114.00 | 76.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 92 | $21,523 | $6,444 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 21 | $4,169 | $1,146 | 27.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,913 | $973.02 | 24.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $2,249 | $758.50 | 33.7% |
About Dr. Patricia Kapsner, MD
Dr. Patricia Kapsner, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710993464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patricia Kapsner, MD has received a total of $22,142 in payments from pharmaceutical and medical device companies, with $198.74 received in 2024. These payments were reported across 93 transactions from 25 companies. The most common payment nature is "" ($18,850).
As a Medicare-enrolled provider, Kapsner has provided services to 562 Medicare beneficiaries, totaling 717 services with total Medicare billing of $36,378. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Albuquerque, NM
- Active Since 08/01/2006
- Last Updated 03/31/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1710993464
Products in Payments
- SIGNIFOR (Drug) $18,850
- Omnipod (Device) $345.83
- Prolia (Biological) $222.57
- Crysvita (Drug) $208.69
- EVENITY (Biological) $200.86
- Korlym (Drug) $137.99
- FREESTYLE LIBRE 3 (Device) $124.20
- Tymlos (Biological) $121.80
- BAQSIMI (Drug) $119.22
- MOUNJARO (Drug) $112.35
- Dexcom G6 Transmitter (Medical Supply) $105.51
- JARDIANCE (Drug) $103.92
- FARXIGA (Drug) $102.40
- TRULICITY (Drug) $98.52
- CeQur Simplicity (Device) $96.11
- CABOMETYX (Drug) $87.32
- NP Thyroid 60 (Drug) $66.59
- Saxenda (Drug) $64.78
- INVOKANA (Drug) $52.41
- TOUJEO (Drug) $43.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Albuquerque
Robert Ferraro, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $159,919
Endocrinology, Diabetes & Metabolism $159,919
Jeremy Gleeson, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $79,052
Endocrinology, Diabetes & Metabolism $79,052
Rina Patel-Trujillo, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $77,508
Endocrinology, Diabetes & Metabolism $77,508
David Schade
Endocrinology, Diabetes & Metabolism — Payments: $41,921
Endocrinology, Diabetes & Metabolism $41,921
Ivan Pinon, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $38,194
Endocrinology, Diabetes & Metabolism $38,194
Neil Kaminsky, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $17,617
Endocrinology, Diabetes & Metabolism $17,617